In gallbladder cancer patients, adjuvant chemotherapy after curative resection significantly enhances survival and reduces recurrence risk.

• The 3-year overall survival rate was higher for chemotherapy patients at 73% versus 43% for those under observation.
• Progression-free survival also showed favorable outcomes for the chemotherapy group.

Consider this data for selecting treatment strategies post-resection, as chemotherapy markedly benefits patient outcomes.

• Study involved 604 patients, with 93 receiving chemotherapy and 511 observed.